Kraig Biocraft Laboratories (KBLB) Change in Accured Expenses (2010 - 2025)

Kraig Biocraft Laboratories has disclosed Change in Accured Expenses across 16 years of filings, most recently posting $326834.0 for Q4 2025.

• Change in Accured Expenses for Q4 2025 came in at $326834.0, up 10.18% year-over-year; the trailing twelve-month figure through Dec 2025 was $947747.0 (up 15.79% YoY), and the FY2025 annual result was $947747.0, up 15.79% from the prior year.
• Change in Accured Expenses came in at $326834.0 for Q4 2025 at Kraig Biocraft Laboratories, up from $207487.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $326834.0 in Q4 2025 to a low of $189.0 in Q2 2021.
• The 5-year median for Change in Accured Expenses is $196339.5 (2024), against an average of $177397.4.
• Across the five-year window, Change in Accured Expenses plunged 99.82% in 2021 and surged 37386.24% in 2022, its largest moves.
• Kraig Biocraft Laboratories' Change in Accured Expenses stood at $158301.0 in 2021, then increased by 18.58% to $187709.0 in 2022, then jumped by 69.95% to $319014.0 in 2023, then declined by 7.02% to $296626.0 in 2024, then gained by 10.18% to $326834.0 in 2025.
• The last three Change in Accured Expenses figures came in at $326834.0 (Q4 2025), $207487.0 (Q3 2025), and $217779.0 (Q2 2025), per Business Quant data.